TRENDING LISTS: Dividend Aristocrats, Dow 30, Largest Market Cap Stocks & Warren Buffett's Portfolio

BIIB $314.55 -5.59 (-1.75%)

Fri, Dec 14, 2018

Biogen Inc is a Health Care stock that trades on the NASDAQ with a market cap of $109.25 Billion

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen markets novel MS drugs Tysabri and Tecfidera independently. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.

If you haven't signed up for Ebates yet, you are definitely leaving money on the table.

Get up to 12% CASH BACK from shopping @ $AMZN, $WMT and $EBAY & $10 Sign Up Bonus (through this link)!

Ebates Coupons and Cash Back

Add (BIIB) to Portfolio

Biogen Inc Stock Charts

The 5 year and 1 year stock charts are below.

50 Day Moving Average

The 50 Day Moving Average is at $322.38 which is 2.43% above the stock price of $314.55.

200 Day Moving Average

The 200 Day Moving Average is at 312.19 which is -0.76% abovethe stock price of $314.55.

BIIB Stock Price

Below are a few key dates for the stock price.

Year To Date


The most recent stock price is $314.55.

The Year To Date (YTD) return is -5.87%.

52 Week Low


The 52 Week Low stock price is $257.52 set on Mon, Apr 9, 2018 which is 251 days ago.

The current price per share is 22.15% above the 52 week low.

52 Week High


The 52 Week High stock price is $383.83 set on Wed, Jul 25, 2018 which is 144 days ago.

The current price per share is -18.05% below the 52 week high.

All Time High

Mar 2015

The All Time High stock price is $438.43 set on Fri, Mar 20, 2015 which is 1,367 days ago.

The current price per share is -28.26% below the all time high.


Below is the EPS, P/E Ratio and Earnings Date.

The Earnings Per Share (EPS) is $7.17.

The Price To Earnings (P/E) Ratio is 20.36.

Earnings Dates

Stocks can make big percentage moves on the earnings announcement.

Companies announce earnings either before the market open or after the close.


The Earnings Release Date for Biogen Inc was Tue, Jul 24, 2018.

Since this earnings release 145 days ago, the stock price is down by -12.17%.


The most recent Earnings Release Date was on Tue, Oct 23, 2018, which was 54 days ago.

Since this earnings date, the stock price is down by -0.31%.

Biogen Inc Dividend

Below is important Dividend information.

BIIB currently does not pay a dividend.

You may like this list of best dividend stocks of 2018.

Industry Stocks

Below are some other Biotech & Pharma industry stocks like Biogen Inc.